What does 4D Molecular Therapeutics, Inc. do?
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is 4D-150 for the…
What is 4D Molecular Therapeutics, Inc.'s P/E and P/B ratio?
4D Molecular Therapeutics, Inc. has a P/E ratio of -4.5 and a P/B ratio of 1.61.
What is 4D Molecular Therapeutics, Inc.'s debt-to-equity ratio?
4D Molecular Therapeutics, Inc. has a debt-to-equity ratio of 0.10.
How much does 4D Molecular Therapeutics, Inc. owe compared with what it owns?
4D Molecular Therapeutics, Inc. owes $0.17 for every $1 it owns (balance sheet Jun 2026), which is low.
What is 4D Molecular Therapeutics, Inc.'s Positivity rank?
4D Molecular Therapeutics, Inc. is ranked #4,261 of 6,774 companies globally and #2,086 of 4,000 in United States on PositoAI, with a Positivity Score of 19,706.
Does 4D Molecular Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for 4D Molecular Therapeutics, Inc..
Where can I read the latest news about 4D Molecular Therapeutics, Inc.?
Recent headlines about 4D Molecular Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does 4D Molecular Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of 4D Molecular Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.